Xin Lang Cai Jing·2025-08-21 01:31Group 1 - The core viewpoint of the news highlights the trading performance and financing activities of Spring Medical, indicating a significant net buying in the financing market on August 20, with a net purchase amount of 4.17 million yuan [1] - On August 20, Spring Medical's financing buy amounted to 12.64 million yuan, with a total financing balance of 47.98 million yuan, representing 0.71% of its market capitalization, which is above the 90th percentile of the past year [1] - The company has not engaged in any short selling activities on August 20, with no shares sold or repaid, indicating a stable position in the short selling market [1] Group 2 - Spring Medical, established on February 12, 1998, specializes in the research, production, and sales of implantable orthopedic medical devices, with its main products including joint prosthetics and spinal implants [2] - As of March 31, Spring Medical reported a revenue of 230 million yuan for the first quarter of 2025, reflecting a year-on-year growth of 3.6%, and a net profit attributable to shareholders of 58.07 million yuan, up 5.2% year-on-year [2] - The company has distributed a total of 359 million yuan in dividends since its A-share listing, with 309 million yuan distributed over the past three years [3] Group 3 - As of March 31, 2025, the number of shareholders in Spring Medical increased by 7.48% to 7,182, while the average circulating shares per person decreased by 6.99% to 11,063 shares [2] - Among the top ten circulating shareholders, Zhonggeng Small Cap Value Stock holds 2.87 million shares, remaining unchanged, while Hong Kong Central Clearing Limited increased its holdings by 1.11 million shares to 2.29 million shares [3] - New shareholders include Ping An Low Carbon Economy Mixed A, which holds 1 million shares, while some funds exited the top ten circulating shareholders list [3]